Related by context. Frequent words. (Click for all words.) 56 acquires 54 Acquires Exclusive 48 reacquisition 46 sublicensed 46 Director Exercises Options 46 reacquire 46 Closes Financing 45 Epson disclaims 45 Movers Roundup 44 obtains 44 Finalizes Acquisition 44 Durect 44 sublicenses 44 CEO Exercises Options 43 reacquired 43 retains 43 Completes Purchase 43 Signs Licensing Agreement 43 Adopts Shareholder Rights 43 Licence Agreement 43 Announces Organizational Changes 43 Extends Tender Offer 43 Teva Pharma 43 Completes Private Placement 43 Q3 Loss Narrows 43 Fred Topel Image 43 Completes Tender Offer 43 Earnings Scorecard 43 Licensing Deal 42 Closes Private Placement 42 Exclusive Distribution 42 terminates 42 Uracyst ® 42 discontinues 42 Enters Into Letter 42 Announces Definitive Agreement 42 divests 42 buys 42 Acquire Assets 42 Announces Termination 42 Acquires 42 Spins Off 42 Q1 Loss Narrows 42 Closes Acquisition 42 Sells Shares 42 Announces Additions 42 CFO resigns 41 Secures Additional 41 Nippon Kayaku 41 unilaterally terminate 41 Shire ADHD 41 Enablex 41 Signs Lease 41 Avinza 41 Transition Therapeutics 41 outlicensing 41 Osteocel 41 antidepressant Wellbutrin XL 41 Signs Joint Venture 41 secures 41 reapplies 41 Patent Dispute 41 acquired 41 exclusivity 41 Signs Long Term 41 Signs Distribution 41 sublicensees 41 Snaps Up 41 Luitpold Pharmaceuticals Inc. 41 Stockholders Approve 41 Enters Strategic 41 Explore Strategic Alternatives 41 Enters Into Agreement 40 Pennsaid R 40 Expands Distribution 40 Numax 40 Movers roundup 40 Holds Annual Meeting 40 Licensing Agreement 40 CFO Resigns 40 rights 40 TechMARK movers 40 Canada Trading Halt 40 Updates Status 40 Completes Initial 40 renegotiates 40 IIROC Halt 40 Bayer Schering 40 UltiMAb R 40 ALZA 40 Obtains 40 Announces Normal Course 40 Par Pharmaceuticals 40 Q4 Profit Surges 40 Announces Successful Completion 39 Capital Invests 39 unpatented claims 39 Chugai Pharmaceutical Japan 39 Closes Sale 39 Captisol 39 Receives Patent